← Back to Search

Actim Pancreatitis Dipstick Test for Acute Pancreatitis

N/A
Waitlist Available
Led By Jeffrey Easler, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up urine dipstick testing assessed 2-3 hours following ercp, for post ercp pancreaitits.
Awards & highlights

Study Summary

This trial will help to determine if a urine test can accurately diagnose pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

Eligible Conditions
  • Post ERCP Acute Pancreatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~urine dipstick testing assessed 2-3 hours following ercp, for post ercp pancreaitits.
This trial's timeline: 3 weeks for screening, Varies for treatment, and urine dipstick testing assessed 2-3 hours following ercp, for post ercp pancreaitits. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity and Specificity of Urine Trypsinogen-2 Dipstick Testing for the Diagnosis of Post-ERCP Pancreatitis

Trial Design

1Treatment groups
Experimental Treatment
Group I: Actim Pancreatitis Dipstick TestExperimental Treatment1 Intervention
All enrolled subjects who meet inclusion/exclusion criteria will have the Urine Trypsinogen 2 Dipstick test done.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Actim Pancreatitis
2017
N/A
~400

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,677 Total Patients Enrolled
1 Trials studying Acute Pancreatitis
800 Patients Enrolled for Acute Pancreatitis
Jeffrey Easler, MD5.01 ReviewsPrincipal Investigator - Indiana University
Indiana University
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to volunteer for this experiment?

"Clinicaltrials.gov indicates that, despite being posted on July 6th 2017 and updated as recently as January 31st 2022, this trial is not actively enrolling patients at present. That said, there are 82 other studies in the same domain currently recruiting new participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis
Jeffrey Easler 2017. "Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03098082.
~51 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top